Kazakhstan vs Marshall Islands: Previously treated cases tested for RR-/MDR-TB
Kazakhstan
100.0%
in 2024
Marshall Islands
100.0%
in 2024
Kazakhstan rank
1st
Marshall Islands rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Kazakhstan
- Marshall Islands
How they compare
Kazakhstan currently reports 100.0% against 100.0% in Marshall Islands, a difference of 0.0%.
The two have swapped places 5 times across 18 shared years of data; in 2006 it was Kazakhstan ahead.
Kazakhstan ranks 1st and Marshall Islands ranks 1st of 180 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 1 and Marshall Islands in 1.
Head to head by decade
| Decade | Kazakhstan | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.0% | 52.7% | 1.7% | Marshall Islands |
| 2010s | 87.4% | 40.9% | 46.5% | Kazakhstan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Kazakhstan or Marshall Islands?
- Kazakhstan, at 100.0% against 100.0% in Marshall Islands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Kazakhstan and Marshall Islands?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Marshall Islands?
- 18 years are reported by both, from 2006 to 2024.
- How do Kazakhstan and Marshall Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Kazakhstan ranks 1st and Marshall Islands ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.